Daratumumab and corticosteroid treatment
Phase 3Small molecule
Daratumumab and corticosteroid treatment is one of 3 small molecule programs targeting Acquired Hemophilia. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in Acquired Hemophilia
#DrugCompanyPhaseTrials
1Hemlibra
RochePhase 2
Daratumumab and corticosteroid treatment
IInstitute of Hematology & Blood Diseases Hospital, China
Phase 3
OBIZUR
TakedaPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Acquired Hemophilia1 trial
Sources
References
- [1]
- [2]
- [3]
- [4]
Details